Loading…
Inhibition of protein kinase C is associated with a decrease in c-myc expression in human myeloid leukemia cells
Treatment of human myeloid leukemic cells with phorbol esters such as 12- O-tetradecanoylphorbol-13-acetate (TPA) is associated with activation and then partial down-regulation of protein kinase C activity. Previous work has suggested that the activation of protein kinase C by TPA contributes to the...
Saved in:
Published in: | FEBS letters 1991-12, Vol.294 (1), p.73-76 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Treatment of human myeloid leukemic cells with phorbol esters such as 12-
O-tetradecanoylphorbol-13-acetate (TPA) is associated with activation and then partial down-regulation of protein kinase C activity. Previous work has suggested that the activation of protein kinase C by TPA contributes to the decrease in
c-myc expression during differentiation of these cells. The present studies demonstrate that the decline in
c-myc mRNA levels following exposure of HL-60 cells to TPA is preceded by an increase in expression of this gene. In contrast, exposure of HL-60 cells to inhibitors of protein kinase C activity is associated with down-modulation of
c-myc expression. Similar findings have been obtained in U-937 myeloid leukemia cells. Taken together, these findings suggest that phorbol esters have a biphasic effect on
c-myc expression. Whereas the activation of protein kinase C by phorbol esters may be associated with an increase in
c-myc gene expression, the subsequent partial down-regulation of kinase activity may initiate a cascade of events resulting in the down-modulation of
c-myc expression. |
---|---|
ISSN: | 0014-5793 1873-3468 |
DOI: | 10.1016/0014-5793(91)81346-A |